Shared from University of Michigan Medicine

A better understanding of inflammation and lung immunity over the past two decades has led to new, innovative treatments for asthma, including biologic therapies. This is especially true for a subtype known as eosinophilic asthma—asthma that’s related to the recruitment and overactivation of white blood cells in the lungs called eosinophils.